Like this article?
Get your free daily medical news from Physician's First Watch.
FDA Approves Two New Combination Vaccines for Children
The FDA has approved a pair of combination pediatric vaccines, the manufacturers recently announced.
The agency has licensed the pentavalent vaccine, Pentacel, for use in children aged 6 weeks through 4 years. The four-dose vaccine immunizes against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b. The vaccine, which was tested in clinical trials of more than 5000 children, is expected to be available in the U.S. this summer.
In addition, a new quadrivalent vaccine, called Kinrix, has been approved to protect against diphtheria, tetanus, pertussis, and polio in children 4 to 6 years old, following a randomized trial of some 3200 children.
LINK(S):
Press release for Pentacel (Free PDF)
Pentacel prescribing information (Free PDF)
Press release for Kinrix (Free)
Published in Physician's First Watch June 26, 2008
Your Remark:
To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.